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Abstract
Objectives: The aim of this work was to assess risk habits, clinical and cellular phenotypes and TP53 DNA changes in 
oral mucosa samples from patients with Oral Potentially Malignant Disorders (OPMD), in order to create models that 
enable genotypic and phenotypic patterns to be obtained that determine the risk of lesions becoming malignant.
Study Design: Clinical phenotypes, family history of cancer and risk habits were collected in clinical histories. 
TP53 gene mutation and morphometric-morphological features were studied, and multivariate models were ap-
plied. Three groups were estabished: a) oral cancer (OC) group (n=10), b) OPMD group (n=10), and c) control 
group (n=8).
Results: An average of 50% of patients with malignancy were found to have smoking and drinking habits. A 
high percentage of TP53 mutations were observed in OC (30%) and OPMD (average 20%) lesions (p=0.000). The 
majority of these mutations were GC → TA transversion mutations (60%). However, patients with OC presented 
mutations in all the exons and introns studied. Highest diagnostic accuracy (p=0.0001) was observed when incor-
porating alcohol and tobacco habits variables with TP53 mutations. 
Conclusions: Our results prove to be statistically reliable, with parameter estimates that are nearly unbiased even 
for small sample sizes. Models 2 and 3 were the most accurate for assessing the risk of an OPMD becoming 
cancerous. However, in a public health context, model 3 is the most recommended because the characteristics 
considered are easier and less costly to evaluate. 
Key words: TP53, oral potentially malignant disorders, risk factors, genotype, phenotype.
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Introduction
Non-communicable chronic diseases (NCCD), such as 
oral cancer, are the leading causes of death in the world 
(1). Eighty percentages of deaths were caused by NCCD, 
occurred in low- and middle-income countries, and can 
be prevented by prevention programs and early diagno-
sis (2). The challenge of multifactorial phenotypes is to 
achieve a valid strategy for identifying risk individuals 
in the population (3).  
Oral cancer (OC) is often preceded by lesions with 
malignant signs, known as oral potentially malignant 
disorders (OPMD). OPMD generate a wide diversity 
of symptoms and signs, making it difficult to identify 
early malignant changes, and the risk factors for OPMD 
are not the same in different countries and regions (4-6). 
Predicting the likelihood of malignant transformation 
of OPMD is thus a major concern for public health stra-
tegies, especially in developing countries. 
Patients who have been diagnosed at an earlier stage of 
OPMD require less aggressive treatment, present less 
morbidity and require lower health costs. The most va-
luable tool is the recognition of individual risks, which 
depends on the availability of methodological strategies 
to identify phenotype-genotype profiles (7,8), hence our 
interest in studying the particular forms in patients with 
OPMD or OC. Non-invasive and easily applicable me-
thods such as cytology, associated with other techniques 
such as well-known TP53 mutations, clinical statements 
and statistical models could provide data to be used for 
the generation of risk models (9,10). Even nowadays, 
there are no reliable marking patterns that describe the 
risk factors of OPMD becoming OC. 
The building of a theoretical model based on basic clini-
cal concepts is essential to evaluate the biodiversity of 
human health and also re-evaluate prediction metho-
dologies to develop new methods for early presumptive 
diagnosis. This model should be founded on current 
conceptions of epidemiology and biostatistics, in order 
to understand the conditions and mechanisms underly-
ing the development of complex chronic diseases.
So the aim of this work was to assess risk habits, clinical 
and cellular phenotypes and TP53 DNA changes in oral 
mucosa samples from patients with OPMD, in order 
to create models that enable genotypic and phenotypic 
patterns to be obtained that determine the risk of lesions 
becoming malignant.
Material and Methods
-Patients 
A cross-sectional study was conducted of a male-fe-
male population (n=28), aged 23-84, attended at the 
Clinical Office of the Stomatology Clinic “A”, (Fa-
culty of Dentistry, National University of Cordoba, 
Argentina) between January 2010 and January 2011. 
This study was approved by the Research and Ethics 
Committee of the Ministry of Health of the province of 
Cordoba (No. 1378) and informed consent forms were 
signed by all patients.
Patients were excluded who were under therapeutic 
medication such as corticosteroids or chemotherapy 
drugs that modify or alter the clinical behavior of ma-
lignant oral lesions. Patients diagnosed with other can-
cers, systemic diseases, chronic alcoholism and drug 
addiction were also excluded.
Three groups were established: a) oral cancer group 
(OC), b) oral potentially malignant disorders group 
(OPMD), and c) control group (Con). The OC and OPMD 
groups were diagnosed by routine histopathological 
analysis; the Con group diagnosis was performed by 
other diagnostic methods.
OC group: patients (n=10) with a diagnosis of oral squa-
mous cell carcinoma and ⁄or verrucous carcinoma (ICD-
10 C00-C06).
OPMD group: patients (n=10) with a diagnosis of 
OPMD according to criteria described by Warnakulas-
uriya et al. (4), who consider OPMD as a family of mor-
phological alterations among which some may have an 
increased potential for malignant transformation; there 
are precancerous lesions (leukoplakia, erythroplakia, 
palatal lesions in reverse smokers) and precancerous 
conditions (submucous fibrosis, actinic keratosis, lichen 
planus, discoid lupus erythematosus). A precancerous 
lesion is morphologically altered tissue in which oral 
cancer is more likely to occur than in its apparently nor-
mal counterpart; a precancerous condition is a general-
ized state associated with a significantly increased risk 
of cancer (4).
Con group: patients (n=8) with oral lesions excluding 
cancer or OPMD.
-Examination of the oral cavity 
The examination was performed by previously calibra-
ted dentists (Kappa = 0.62), through visual inspec-
tion and palpation of oral mucosa, teeth and prosthet-
ic devices (removable⁄fixed). Tongue, lip and cheek 
parafunction habits were also registered. Patients were 
asked about lifestyle, age, gender, ethnicity, smoking 
and alcohol habits and other information. Following 
Piemonte et al. (11), smokers are those who consumed at 
least one cigarette per day for a minimum period of one 
year; drinkers are patients who consume two measures 
of alcohol per week for a minimum period of one year.
-Exfoliative Cytology
Two smears from the lesion were collected using cy-
tobrush Medibrush ®Plus, Medical Engineering (Ar-
gentina). One of the smears was fixed in 96% alcohol 
for 1 h, and then Papanicolaou stained (12). The other 
smear was stored in sterile H2O at - 80°C for DNA 
extraction. For morphometric analysis, 30 cells from 
each patient were selected. The cells were evalua-
ted using an Olympus BX50 optical microscope and 
Med Oral Patol Oral Cir Bucal. 2013 Sep 1;18 (5):e759-65.                                                                                                                                                                        Risk models for oral lesions
e761
the images were captured with a SONY video came-
ra and Image-ProPlus software, 1999. For the total 
amount of cells that were selected from each group of 
lesions (n=300), the nuclear area (NA), cytoplasmic 
area (CA), and NA/CA ratios were measured using 
Autocad 2000 software. Only clearly defined cells 
were measured in each smear and the mean value of 
NA and CA was obtained for each case. In all cases, 
the cytoplasmic area and nucleus area were measured 
in square micrometers.
-DNA isolation and Polymerase Chain Reaction (PCR)
DNA was extracted according to the amended protocol 
described in Brunotto et al. (13). Cells collected from 
brushing lesion were resuspended in 2:5 of 70% alcohol 
and sterile water. They were then centrifuged at 10000 
rpm and afterwards incubated in 7μl of proteinase K 
(1mg/ml) in 150μl of extraction buffer.for 30 min at 
50ºC. They were later centrifuged for 5 min at 14000 
rpm, the supernatant was recovered and 0.8-1 volume 
of isopropyl alcohol was added. It was later centrifuged 
again, eliminating the supernatant, and washed in 70% 
alcohol for centrifugation for 5 min at 10000 rpm. Fi-
nally, the DNA was resuspended in 150 μl of 1x buffer 
TE(Tris/EDTA). The 260/280 absorbance ratio of the 
DNA employed for PCR was ≥ 1.70. Primers were de-
signed in order to amplify the following regions of the 
human TP53 gene (GeneBank: NC_000017):
▪exons 5-6  Forward: 5’-ACAGTACTCCCCTGCCCT-
CAACAA-3’, 
Reverse: 5’-CCCAGTTGCAAACCAGACCTCAG-3’
▪exons 7-8  Forward: 5’- TGTGTTATCTCCTAGGTT-
GGCTCTGACT-3’; 
Reverse: 5’-TGCTTGCTTACCTCGCTTAGTGCTC-3’ 
The PCR was obtained in a 50 μl final volume. PCR am-
plification was carried out on BioRad’s iCycler thermal 
cycler, using the following protocol: 10 min at 95ºC, 1 
min at 95ºC, 1 min at 62ºC, and 2 min at 72ºC for 40 
cycles, with an additional 10 min at 72ºC after the last 
cycle. The PCR products were separated on 0.8% TBE 
(Tris/Borate/EDTA) agarose gel and stained with ethid-
ium bromide. A DNA ladder marker (Promega, USA) 
was used to determine the size of DNA fragments. The 
fragments were purified and sequenced at Macrogen 
Inc., Seoul, South Korea.
-Statistical Analysis and Models
Data analysis was as follows:
a) The Chi Square Test was performed to evaluate asso-
ciations or difference of proportions among the groups, 
setting p<0.05 for statistical significance.
b) The Kappa coefficient was calculated to evaluate the 
concordance between dentists, setting a value equal to 
or higher than 0.6 for good concordance.
c) Logit Regression (LR) models were built combin-
ing different covariables, in order to discriminate main 
factors between OC and OPMD. Age, gender, cellular 
phenotype (presence of cellular atypia in oral smears), 
genotype (mutations in exon-introns 5 to 8 TP53 DNA 
sequence), and smoking/alcohol consumption habits in 
patients were included as predictor variables. The ma-
lignant lesions variable was the binary outcome (OPMD: 
1; OC: 0). The models built were:
0 1 2 3
4
log ( ) + FliaInheritance+ mutationTP53+ timedevelopment
                         + Alterationsrationucleus/cytoplasm
OPMDit diag b b b b
b
=
0 1 2 3
4
log ( ) + habits+ mutationTP53+ timedevelopment 
                          + Alterationsrationucleus/cytoplasm
OPMDit diag b b b b
b
=
0 1 2
3
log ( ) + habits+ timedevelopment
                         + Alterationsrationucleus/cytoplasm
OPMDit diag b b b
b
=
d) The diagnostic accuracy of each model was assessed 
by the Area Under of the Receiver Operating Characte-
ristic (AUC of ROC curve) estimated by non-parametric 
methods (14).
The parameters were estimated by Monte Carlo, which 
was applied because of the small sample size (15).
Results
-Clinical and biodemographic characteristics 
In the Con group there was a high percentage of female 
patients (62.5%), while in the OC and OPMD groups 
most patients were male (p=0.000) (Table 1). The ma-
jority of patients were 45 years of age or more, princi-
pally in the OC and OPMD groups (p=0.0007) (Table 
1). Patients with OPMD lesions (n=10) presented oral 
leukoplakia (OL, 40%) and oral lichen planus (OLP, 
60%). The age of the lesion was greater than a year in 
all groups (p=0.0766) (Table 1). An average of 85% of 
patients with OPMD and OC were found with smoking 
and drinking habits (p=0.000) (Table 1).
-Cellular and molecular characteristics
Morphometric analysis showed normal features in the 
NA/CA ratio, and significant proportions of OC patients 
in the Con and OPMD groups (p=0,000) (Table 1).
A high percentage of TP53 mutations were observed in 
OC (30%) and OPMD (average 20%) lesions (p=0.000) 
(Table 2). Most of these are guanine-cytosine to thym-
ine-adenine (GC → TA) transversion mutations (60%). 
In contrast, patients with OC presented mutations in all 
the exons and introns studied (Table 2).
-Prediction models
All estimated AUCs showed a high diagnostic accuracy 
for each model built. Highest diagnostic accuracy was 
observed when incorporating the TP53 mutations, NA/
CA ratio alterations, and alcohol and tobacco habits 
variables (98%) (Table 3). 
Fig. 1. Model 1 (M1)
Fig. 2. Model 2 (M2)
Fig. 3. Model 3 (M3)
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Features of patients 
Group p-value(*) 
 
Con (n=8) 
%RF; (AF) 
Problem (Type of mailignant condition)  
Chi Square 
 Test 
OC (n=10) 
%RF;(AF) 
OPMD (n=10) 
OL (n=4) 
%RF;(AF) 
OLP(n=6) 
%RF;(AF) 
Biodemographic aspects Gender:  Female 
              Male 
62.5; (5) 
37.5; (3) 
40.0; (4) 
60.0; (6) 
50.0; (2) 
50.0; (2) 
33.3 (2) 
66.7; (4) 
0.0000 
Age (>45 years) 62.5; (5) 70.0; (7) 75.0;   (3) 100.0; (6) 0.0007 
Cellular and molecular 
aspects 
Ratio Nuclear/Cytoplasmic area > 0.28(a) 37.5; (3) 60.0;  (6) 75.0;   (3) 83,3 (5) 0.0000 
Presence TP53 Mutation 0.0; (0) 30.0;   (3) 25.0;   (1) 16.7; (1) 0.0000 
 
 
Clinical aspects 
Presence Familiar Inheritance Cancer 50.0;  (4) 60.0;   (6) 25.0;   (1) 50.0; (3) 0.0006 
Lesion's Time > 1 year 75.0; (6) 100.0; (10) 100.0;   (4) 100.0; (6) 0.0766 
Lesion’s site Yugal mucosa 12.5; (1) 50; (5) 0.0; (0) 16.7; (1)  
 
0.6039 
Palatine mucosa 0.0; (0) 30; (3) 100; (4) 0.0; (0) 
Lip mucosa 0.0; (0) 10; (1) 0.0; (0) 33.3; (2) 
Tongue 25; (2) 10; (1) 0.0; (0) 16.7; (1) 
Other sites 62.5; (5) 0.0; (0) 0.0; (0) 33.3; (2) 
Habits of risk Smoke and/or drinking 50.0; (4) 70.0;   (7) 100.0;   (4) 50.0; (3) 0.0000 
Table 1. Features of patients under study. OL: Oral Leukoplakia; OC: Oral Carcinoma; OLP: Oral Lichen Planus; OPMD: Oral Potentially Ma-
lignant Disorders; Con: control (*) Estimated by Monte Carlo based 10000 sampling tables with initial seed 2000000, setting p<0.05 by statistical 
significance of association among lesions and features. (a) Median value used as cut-point. All adjusted for age and gender. %RF: % of relative 
frequencies of patients with features in relation to total of patients in the category; AF: absolute frequencies of patients in the category. 
DNA  region Number of total 
mutations observed Con(a)
 %RF; (AF)
Problem (Type of mailignant condition) p-values
OC (a)
%RF;(AF)
OPMD (a)
OL 
%RF;(AF)
OLP
%RF;(AF)
Chi-Square 
Test
Exon 5 10 0; (0) 30; (3) 10; (1) 60; (6) 0.013
Exon 6 12 0; (0) 50; (6) 8.3; (1) 41.7; (5) 0.000
Exon 7 4 0; (0) 50; (2) 25; (1) 25; (1) 0.000
Exon 8 4 0; (0) 50; (2) 25; (1) 25; (1) 0.000
Intron 5-6 8 0; (0) 50; (4) 12.5; (1) 37.5; (3) 0.002
Intron 7-8 2 0; (0) 50; (1) 0; (0) 50; (1) 0.000
Table 2. Patients with different kind of lesions presented mutation in the DNA sequenced. Each patient has sequenced the 5-8 exons. Bp: base 
pair; Con: control; OL: Oral Leukoplakia; OC: Oral Carcinoma; OLP: Oral Lichen Planus; OPMD: Oral Potentially Malignant Disorders. %RF: 
% of relative frequencies of change bases in relation to total of change bases in the category; AF: absolute frequencies of change bases in the 
category. (a) Chi-Square Test among proportions of exons/introns, p-values estimated by Monte Carlo, initial seed= 2000000, setting p<0.05 by 
statistical significance among porportions.
Discussion
Nowadays, there is a focus on complex diseases, with 
researchers seeking to improve the accuracy of early 
diagnosis of these pathologies, since dissimilar pheno-
types can be obtained in similar cellular and symptom 
conditions. For that reason, this study combined differ-
ent variables, such as clinical phenotypes and genotypes 
as well as habits, in order to create models that enable 
genotypic and phenotypic patterns to be obtained in pa-
tients with OPMD, using non-invasive methods such as 
Med Oral Patol Oral Cir Bucal. 2013 Sep 1;18 (5):e759-65.                                                                                                                                                                        Risk models for oral lesions
e763
Table 3. Partial models of Regression Logit (RL) were built, Under Area ROC Curve (UAC) calculated with estimated RL probabilities 
and the  corresponding p-value of UAC (estimated by non parametric methods). All models were ajusted by gender and age. M: model. 
OPMD: Oral Potentially Malignant Disorders.
RL  models UAC p-value
M1
0 1 2 3
4
log ( ) + FliaInheritance+ mutationTP53+ timedevelopment
                         + Alterationsrationucleus/cytoplasm
OPMDit diag ? ? ? ?
?
? 0.81 0.0009 
M2
0 1 2 3
4
log ( ) + habits+ mutationTP53+ timedevelopment 
                          + Alterationsrationucleus/cytoplasm
OPMDit diag ? ? ? ?
?
? 0.98 0.0000 
M3
0 1 2
3
log ( ) + habits+ timedevelopment
                         + Alterationsrationucleus/cytoplasm
OPMDit diag ? ? ?
?
? 0.96 0.0000 
exfoliative cytology (16). We included oral lichen pla-
nus lesions as OPDM. This is controversial because the 
major problem of interpretation of malignant potential 
studies of this disease is the inexistence of strict diag-
nostic criteria for differentiating lichenoid processes 
(17). Even though the WHO classifies OLP as a prema-
lignant condition, the underlying mechanisms initiating 
the development of cancer in OLP lesions are still not 
understood (18).
It is known that surgical biopsy is the definitive method 
for diagnosing oral lesions, but this is invasive and has 
technical constraints and psychological implications for 
patients. It is impractical to perform a biopsy routinely 
within screening programs or follow-up control stud-
ies (19). Our results obtained through the morphometric 
study showed that the proportion of OC patients with a 
nucleus/cytoplasm ratio greater than 28 micras is higher 
than in other groups studied. Diniz-Freitas et al. (20), 
who studied oral smears from healthy patients and pa-
tients with oral carcinomas, concluded that neither the 
cytoplasm area, the nucleus area, or the ratio between 
them are significant parameters to differentiate between 
oral smears of patients. In addition, Ramaesh et al. (21), 
using nuclear and cytoplasmic diameter, found no differ-
ence between normal mucosa and dysplastic lesions of 
the oral mucosa. However, Mehrotra et al. (22) consider 
that this method is important for detecting these lesions 
and predicting their progression or recurrence. On the 
other hand, Navone et al. (23) demonstrated that exfo-
liative cytology presented a sensitivity of 86.5% and an 
accuracy of 89.6% in detecting patients with dysplasia 
and/or carcinoma. They found that the single case that 
was histologically negative at the onset proved positive 
at cytology. All this strongly suggests that cytomorpho-
metric features are not relevant by themselves as a test of 
prevention or diagnosis, but this methodology is useful 
for collecting cells for several analyses and, accompanied 
by other clinical and molecular signs, should be used as a 
non-invasive strategy to uncover the nature of cancer if a 
lesion is clinically benign or potentially malignant (24).
We observed TP53 mutations on exons 5-8 in OPMD 
(10%) and OC (15%). Ogmundsdóttir et al. (25) confirm 
these results, since they observed that TP53 mutations 
can exist in benign oral mucosal lesions or in the recur-
rence of oral squamous cell carcinoma lesions. In fol-
low-up studies of patients with oral, larynx, hypophar-
ynx and oral squamous cell carcinomas, most patients 
who had a family history of cancer presented mutations 
in the TP53 gene in germline cells (26). The presence of 
mutations in the specific DNA binding site is one com-
pulsory indicator characteristic of a patient deemed to 
be at risk that should be incorporated into a monitor-
ing program. Moreover, the TP53 marker used in this 
work is well-known and its usage widespread, involving 
a lower economic cost than others, and it does not need 
specialized staff to interpret its results. 
In our study, we observed that a significantly high percent-
age of patients with OC and OL had smoking and drinking 
habits. These results match those of other investigations 
in which smoking and drinking habits have been strongly 
linked to the presence of OC and OPMD (11).
Considering the multifactorial concept of OC and 
OMPD (5,11), we built logistic models from genotype 
and phenotype variables that allow patients with OPMD 
and OC to be classified, using statistical tools to deter-
mine the probability of including a patient in either 
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group. When considering variables such as tobacco and 
alcohol habits and the presence of the TP53 mutation 
in exons 5-8, the accuracy of the probability of clas-
sifying patients increased to 94-96%. It is known that 
tumorigenesis involves several steps, the first one be-
ing the sequential accumulation of genetic mutations, 
closely related to environmental determinants, followed 
by a clonal proliferation (5).  
Prevention of cancer offers the greatest public health 
potential and the most cost-effective long-term method 
of cancer control; besides, early detection helps reveal 
the presence of the disease at an initial stage, when it 
has a high potential for cure. The assessment of the 
value of diagnostic indicators, such as symptoms and 
genetic testing, enables the sensitivity and specificity of 
these indicators for determining the presence/absence 
of a malignant pathology to be estimated. Lingen et al. 
(27) considered that a description of biomarker profiles 
is necessary and determine a correlation of changes in 
biomarker profiles over time in relation to the progres-
sion from OPMD to cancer.
We show that patients with OPMD share features with OC 
patients such as clinical patterns, TP53 changes and drink-
ing and tobacco habits, and thus it would be interesting   to 
conduct multivariate studies to analyze a set of variables.
We also propose a model of malignancy in OPMD, indi-
cating the main features of indicators of oral cancer risk. 
This model is supported by the genetic alterations that 
have been shown to contribute directly to malignant de-
velopment and progression and which are central to un-
derstanding the pathway of genes as well as the various 
phenotypes they generate (27). Both epidemiological 
(28) and experimental studies (29) indicate that tobacco 
and alcohol consumption is a risk factor for developing 
OC. Supporting these findings, research performed in 
experimental models showed that cigarette smoke ex-
posure leads to quantitative increases in DNA-binding 
activities of p53 and other proteins (29).
The statistical methods show that the results are reliable 
because they produce parameter estimates that are near-
ly unbiased even for small sample sizes. In our previous 
research conducted from 2000 to 2007 in a population 
of 406 subjects, 16% (65 patients) presented oral can-
cer and 11% (45 patients) were diagnosed with OPMD. 
These data represent about 6 to 10 patients per year with 
OPMD or OC respectively (11). 
Our results permit us to conclude that the presence of TP53 
mutation in exon-introns 5 to 8, associated with the pres-
ence of habits of alcohol and smoking, may be considered 
as main risk factors of malignancy transformation. 
Models 2 and 3 were the most accurate for assessing the 
risk of OPMD becoming cancer. However, in the public 
health context, model 3 is most recommended because 
the characteristics considered are easier and less costly 
to evaluate. 
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